These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 8725984)

  • 1. Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapy.
    Simsek H; Kadayifci A
    J Int Med Res; 1996; 24(3):239-45. PubMed ID: 8725984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K; Reinhold D; Ansorge S
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
    Abe S; Narita R; Matsuhashi T; Oto T; Tabaru A; Otsuki M
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):373-8. PubMed ID: 18403937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre- and post antiviral treatment.
    Jia H; Du J; Zhu S; Ma Y; Cai H
    Chin Med J (Engl); 2003 Apr; 116(4):605-8. PubMed ID: 12875732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
    Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
    Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group.
    Naveau S; Balian A; Degos F; Daurat V; Chevret S; Gayno S; Bastie A; Riachi G; Bartolomei-Portal I; Barange K; Moussalli J; Bailly F; Chaumet-Riffaud P; Emilie D
    J Hepatol; 1999 Oct; 31(4):612-7. PubMed ID: 10551383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
    Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.
    Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M
    Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin-2 receptor levels before and during interferon treatment in patients with chronic hepatitis B virus infection.
    Sawayama Y; Hayashi J; Kawakami Y; Furusyo N; Ariyama I; Kishihara Y; Ueno K; Kashiwagi S
    Dig Dis Sci; 1999 Jan; 44(1):163-9. PubMed ID: 9952238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
    Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
    Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
    Doganay S; Evereklioglu C; Er H; Türköz Y; Sevinç A; Mehmet N; Savli H
    Eye (Lond); 2002 Mar; 16(2):163-70. PubMed ID: 11988817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.
    Cimino G; Amadori S; Cava MC; De Sanctis V; Petti MC; Di Gregorio AO; Sgadari C; Vegna L; Cimino G; Mandelli F
    Leukemia; 1991 Jan; 5(1):32-5. PubMed ID: 1999955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa.
    Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Soppi E
    Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):337-54. PubMed ID: 8872489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis.
    Alberti A; Chemello L; Fattovich G; Pontisso P; Semenzato G; Colletta C; Vinante F; Pizzolo G
    Dig Dis Sci; 1989 Oct; 34(10):1559-63. PubMed ID: 2507263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of soluble interleukin-2 receptors and effects of interferon-alpha for patients with chronic hepatitis C virus.
    Hayashi J; Kishihara Y; Yamaji K; Yoshimura E; Ohmiya M; Tani Y; Ikematsu H; Kashiwagi S
    Dig Dis Sci; 1995 Aug; 40(8):1837-41. PubMed ID: 7648988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion.
    Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH
    Lung; 2001; 179(3):175-84. PubMed ID: 11891607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
    Gur A; Dikici B; Nas K; Bosnak M; Haspolat K; Sarac AJ
    BMC Gastroenterol; 2005 Sep; 5():30. PubMed ID: 16171525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.